ClinicalTrials.Veeva

Menu

Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hypertension Epidemiology Medication Satisfaction Study) (K-HEMS)

B

Boryung

Status

Completed

Conditions

Hypertension

Study type

Observational

Funder types

Industry

Identifiers

NCT02394392
BR-FMS-OB-401

Details and patient eligibility

About

  1. Investigate the clinical characteristics, medication satisfaction and quality of life of anti-hypertensive drugs in Korean hypertensive patients
  2. Observe the changes of medication satisfaction and compliance in patients after switchting to Fimasartan

Enrollment

12,691 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Step1

  • Over 20 years old
  • Essential hypertensive patients who taking anti-hypertensive drugs during previous 1 month

Step2

  • Patients does not taking Fimasartan
  • Patient's medication satisfaction score under 4

Exclusion criteria

  • Patients with secondary hypertension
  • Patients with orthostatic hypotension who has sign and symptom
  • Patients with known severe or malignancy retinopathy
  • Patients with significant investigations; abnormal renal function
  • Childbearing and breast-feeding women
  • Patients with history of allergic reaction to any angiotensin II antagonist

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems